INKT MiNK Therapeutics, Inc.

Fundamentals / CIK 0001840229 / USD

MiNK Therapeutics, Inc. reported $8.24M in total assets and a net loss of $11.02M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INKT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$28.25MFY 2020 Net Income: -$16.24M2020FY 2021 Net Income: -$30.21M2021FY 2022 Net Income: -$27.99M2022FY 2023 Net Income: -$22.46M2023FY 2024 Net Income: -$10.78M2024FY 2025 Net Income: -$12.49M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $5.76M $6.34M $15.49M $23.12M $13.97M $9.51M
Operating Income -$12.64M -$11.29M -$22.92M -$30.95M -$28.36M -$14.64M
EBITDA -$12.46M -$11.07M -$22.72M -$30.83M -$28.28M -$14.58M
Interest Expense -$110K -$93K -$28K -- $2.43M $2.44M
Net Income -$12.49M -$10.78M -$22.46M -$27.99M -$30.21M -$16.24M
Basic EPS -$2.93 -$2.86 -$6.54 -$8.30 -$11.60 -$6.70
Diluted EPS -$2.93 -$2.86 -$6.54 -$8.30 -$11.60 -$6.70
Basic Shares Outstanding 4.3M 3.8M 3.4M 3.4M 2.6M 2.4M
Diluted Shares Outstanding 4.3M 3.8M 3.4M 3.4M 2.6M 2.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $200K -- -- -- $0 -- -- --
Research & Development $1.80M $1.89M $1.20M $1.51M $1.14M $1.84M $1.26M $1.41M
Operating Income -$2.64M -$3.22M -$2.88M -$2.71M -$3.18M -$4.05M -$2.70M -$2.50M
EBITDA -$2.60M -$3.18M -$2.85M -$2.67M -$3.14M -$4.00M -$2.65M -$2.45M
Interest Expense -$1.0K -$2.0K -$4.0K -$29K -$25K -$27K -$29K -$30K
Net Income -$2.55M -$3.13M -$2.74M -$2.60M -$2.89M -$4.24M -$2.77M -$2.46M
Basic EPS -$0.50 -$0.62 -$0.57 -- -$0.65 -$1.06 -$0.70 --
Diluted EPS -$0.50 -$0.62 -$0.57 -- -$0.65 -$1.06 -$0.70 --
Basic Shares Outstanding 5.1M 5.0M 4.8M -- 4.4M 4.0M 4.0M --
Diluted Shares Outstanding 5.1M 5.0M 4.8M -- 4.4M 4.0M 4.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $13.36M $4.58M $3.37M $19.64M $38.89M $2.69M
Cash & Short-Term Investments $13.36M $4.58M $3.37M $19.64M $38.89M $2.69M
Other Current Assets $211K $164K $178K $470K $744K $914K
Total Current Assets $13.85M $4.99M $3.60M $20.40M $39.63M $4.10M
Property, Plant & Equipment, Net $391K $733K $954K $1.07M $607K $458K
Total Non-Current Assets $391K $733K $954K $1.07M $607K $458K
Total Assets $14.24M $5.72M $4.55M $21.47M $40.24M $4.56M
Accounts Payable $3.43M $2.73M $3.91M $5.82M $3.00M $3.14M
Other Current Liabilities $2.85M $2.36M $2.45M $2.62M $5.76M $5.69M
Total Current Liabilities $13.03M $6.96M $11.40M $12.68M $16.47M $14.22M
Other Non-Current Liabilities -- $0 $48K $108K -- $383K
Total Non-Current Liabilities $15.44M $18.35M $11.21M $9.19M $0 $44.21M
Total Liabilities $28.47M $25.31M $22.61M $21.87M $16.47M $58.43M
Common Stock $48 $40 $35 $339 $335 $242
Retained Earnings -$156.7M -$144.2M -$133.4M -$110.9M -$82.95M -$52.74M
Accumulated Other Comp. Income -$719K -$632K -$431K -$292K -$625K -$1.52M
Total Stockholders' Equity -$14.23M -$19.59M -$18.06M -$401K $23.78M -$53.87M
Total Equity -$14.23M -$19.59M -$18.06M -$401K $23.78M -$53.87M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $7.47M $8.81M $9.53M $13.36M $9.50M $1.68M $3.23M $4.58M
Cash & Short-Term Investments $7.47M $8.81M $9.53M $13.36M $9.50M $1.68M $3.23M $4.58M
Other Current Assets $85K $212K $232K $211K $32 $55K $109K $164K
Total Current Assets $7.90M $9.30M $10.02M $13.85M $14.53M $2.01M $3.58M $4.99M
Property, Plant & Equipment, Net $339K $318K $355K $391K $429K $473K $688K $733K
Total Non-Current Assets $339K $318K $355K $391K $429K $473K $688K $733K
Total Assets $8.24M $9.62M $10.38M $14.24M $14.96M $2.48M $4.27M $5.72M
Accounts Payable $4.49M $3.92M $3.39M $3.43M $3.69M $3.31M $2.66M $2.73M
Other Current Liabilities $2.37M $2.45M $2.57M $2.85M $2.76M $2.48M $2.37M $2.36M
Total Current Liabilities $8.18M $7.57M $7.29M $13.03M $13.43M $13.16M $12.12M $6.96M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $16.32M $16.07M $15.78M $15.44M $15.04M $14.51M $13.94M $18.35M
Total Liabilities $24.49M $23.64M $23.06M $28.47M $28.48M $27.67M $26.06M $25.31M
Common Stock $52 $52 $51 $48 $46 $40 $40 $40
Retained Earnings -$165.1M -$162.5M -$159.4M -$156.7M -$154.1M -$151.2M -$146.9M -$144.2M
Accumulated Other Comp. Income -$704K -$700K -$697K -$719K -$692K -$719K -$662K -$632K
Total Stockholders' Equity -$16.25M -$14.03M -$12.69M -$14.23M -$13.51M -$25.19M -$21.79M -$19.59M
Total Equity -$16.25M -$14.03M -$12.69M -$14.23M -$13.51M -$25.19M -$21.79M -$19.59M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.49M -$10.78M -$22.46M -$27.99M -$30.21M -$16.24M
Depreciation & Amortization $182K $215K $205K $122K $78K $55K
Stock-Based Compensation $2.67M $1.81M $3.86M $3.03M $1.74M $88K
Change in Payables $690K -$1.18M -$1.92M $2.66M -$152K $608K
Operating Cash Flow -$5.93M -$9.56M -$15.76M -$18.87M -$12.83M -$8.34M
Capital Expenditure -- -- -$74K -$250K -$249K -$95K
Free Cash Flow -- -- -$15.84M -$19.12M -$13.08M -$8.43M
Investing Cash Flow -- -- -$74K -$250K -$249K -$95K
Common Stock Issued $14.45M -- -- -- -- --
Financing Cash Flow $14.72M $10.82M -$407K -$156K $49.26M $11.11M
Net Change in Cash $8.78M $1.21M -$16.27M -$19.25M $36.20M $2.39M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.55M -$3.13M -$2.74M -$2.60M -$2.89M -$4.24M -$2.77M -$2.46M
Depreciation & Amortization $36K $36K $36K $39K $44K $49K $51K $54K
Stock-Based Compensation $333K $422K $630K $566K $621K $897K $591K $390K
Change in Payables $570K $527K -$32K -$270K $382K $646K -$69K $374K
Operating Cash Flow -$1.28M -$2.08M -$1.73M -$2.07M -$941K -$1.57M -$1.34M -$1.73M
Common Stock Issued $0 $1.37M $3.02M -- -- -- -- --
Financing Cash Flow $0 $1.37M -$2.10M $1.18M $13.55M $540 $576 -$3
Net Change in Cash -$1.34M -$719K -$3.83M -$921K $12.60M -$1.55M -$1.34M -$1.75M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -- -- -127.1% --
Return on Assets (ROA) -87.7% -188.5% -493.3% -130.4% -75.1% -356.5%
Current Ratio 1.06x 0.72x 0.32x 1.61x 2.41x 0.29x
Quick Ratio 1.03x 0.66x 0.30x 1.55x 2.36x 0.19x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -133.7% -118.1% -120.2% -87.7% -82.6% -453.8% -228.2% -188.5%
Current Ratio 0.97x 1.23x 1.38x 1.06x 1.08x 0.15x 0.30x 0.72x
Quick Ratio 0.91x 1.16x 1.31x 1.03x 0.71x 0.13x 0.27x 0.66x
Source: SEC EDGAR CompanyFacts (CIK 0001840229) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal